SAN FRANCISCO, Nov. 13 – Pfizer joined Accelrys’ High Throughput Crystallography Consortium, Accelrys announced Tuesday.

Princeton, N.J.-based Accelrys, a subsidiary of Pharmacopeia, created the consortium to explore and validate rapid methods for X-ray structure determination, model building, and structure validation, according to the company.  The agreement with Pfizer covers a number of sites, including Sandwich, UK, Groton, Ann Arbor and La Jolla.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.